Location: Boston, MA
CIK: 0001637359 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 4, 2018
Total Value: $102M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Paratek Pharmaceuticals | 2,600,410 | $33.8M | 33.2% | $34.18 | — | Common Stock | 699374302 |
| SNNAQ | Sienna Biopharmaceuticals | 758,610 | $14.25M | 14.0% | $21.95 | -20.4% | Common Stock | 82622H108 |
| — | ObsEva | 1,000,000 | $13.49M | 13.3% | $9.76 | — | Common Stock | H5861P103 |
| — | Jounce Therapeutics | 529,965 | $11.85M | 11.6% | $21.99 | — | Common Stock | 481116101 |
| — | CymaBay Therapeutics | 551,477 | $7.164M | 7.0% | $4.71 | — | Common Stock | 23257D103 |
| — | FibroGen | 130,646 | $6.036M | 5.9% | $27.34 | — | Common Stock | 31572Q808 |
| — | Pieris Pharmaceuticals | 778,230 | $5.308M | 5.2% | $1.83 | — | Common Stock | 720795103 |
| — | ESSA Pharma | 21,696,969 | $4.122M | 4.1% | $0.58 | — | Common Stock | 29668H104 |
| — | Dicerna Pharmaceuticals | 223,457 | $2.136M | 2.1% | $16.47 | — | Common Stock | 253031108 |
| — | Egalet | 2,889,926 | $1.821M | 1.8% | $5.98 | — | Common Stock | 28226B104 |
| — | Cidara Therapeutics | 444,965 | $1.78M | 1.7% | $10.40 | — | Common Stock | 171757107 |